Lenz Therapeutics, Inc. · NASDAQ:LENZ
Ra Capital Management, L.P. reported a 13.60% stake in Lenz Therapeutics, Inc. (Schedule 13D/A)
Event Nov 5, 2025 · Filed Nov 7, 2025
Ra Capital Management, L.P. reported a 13.60% stake in Lenz Therapeutics, Inc., 4,265,106 shares, with active intent on Nov 5, 2025. Filed Nov 7, 2025 (Schedule 13D/A).
- Stake
- 13.60%
- Shares
- 4,265,106
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 13.60% | 4,265,106 |
| Peter Kolchinsky | 13.60% | 4,265,106 |
| Rajeev Shah | 13.60% | 4,265,106 |
| RA Capital Healthcare Fund, L.P. | 10.80% | 3,373,921 |
Source
Related
- Lenz Therapeutics, Inc.
- Ra Capital Management, L.P.
- Lenz Therapeutics, Inc. shareholders
- Schedule 13D/A · Ra Capital Management, L.P. · May 9, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 21, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Schedule 13G · Millennium Management LLC · Jun 26, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G · Squarepoint Ops LLC · Apr 8, 2026